不变的TCR触发的蛋白激酶D激活介导NKT细胞发育
Eri Ishikawa1,2, Hidetaka Kosako3, Daisuke Motooka4
1Department of Molecular Immunology, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan.
The Journal of experimental medicine
|September 18, 2025
概括
蛋白激酶D (PKD) 对于不变的自然杀手T (iNKT) 细胞发育至关重要,它通过通过转录因子Ikaros将不变的T细胞受体 (iTCR) 信号与前列细胞白血病指 (PLZF) 诱导联系起来.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 胸腺中不变的自然杀手T (iNKT) 细胞的发展取决于不变的T细胞受体 (iTCR) 和CD1d相互作用.
- 这些相互作用会诱导转录因子前兆细胞白血病指 (PLZF),但上游信号通路尚未完全理解.
研究的目的:
- 阐明在iNKT细胞发育过程中将iTCR参与与PLZF诱导连接的信号通路.
- 确定参与这一关键免疫细胞分化过程的关键分子参与者.
主要方法:
- 利用T细胞特异性蛋白激酶D (PKD) 缺乏的小鼠 (Prkd2/3∆CD4) 来评估PKD的作用.
- 使用具有酸化缺陷的Ikaros (Ikzf1S267/275A) 和缺少PLZF基因Ikaros结合位点 (Zbtb16∆IBS) 的小鼠的试验小鼠.
- 分析了PLZF诱导,iNKT细胞生成,以及Ikaros在PLZF基因上的转录活性.
主要成果:
- PKD缺陷严重损害了PLZF诱导和iNKT细胞生成,可以通过PLZF转基因表达来挽救.
- 在iTCR刺激时,PKD被确定为一种酸化酶Ikaros.
- 酸化缺陷的Ikaros突变体和缺乏PLZF基因Ikaros结合部位的小鼠显示iNKT细胞发育受损,而常规T细胞不受影响.
结论:
- 蛋白激酶D (PKD) 在iNKT细胞中充当iTCR信号和PLZF诱导之间的关键环节.
- 通过酸化Ikaros,PKD通过PKD调解iNKT细胞的发育,这随后驱动了PLZF转录.
相关概念视频
Receptor Tyrosine Kinases
18.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.0K
T Cell Activation and Clonal Selection
14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
Enzyme-linked Receptors
86.0K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.0K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K


